{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:10:42Z","timestamp":1782277842157,"version":"3.54.5"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["20\/317"],"award-info":[{"award-number":["20\/317"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020419","name":"Buchanan Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001518","name":"Maurice and Phyllis Paykel Trust","doi-asserted-by":"publisher","award":["203134"],"award-info":[{"award-number":["203134"]}],"id":[{"id":"10.13039\/501100001518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["1323001"],"award-info":[{"award-number":["1323001"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejphar.2025.178442","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:27:28Z","timestamp":1764894448000},"page":"178442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inhibiting the NLRP3 inflammasome pathway: An effective way to treat chronic inflammation in experimental autoimmune uveitis"],"prefix":"10.1016","volume":"1011","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0739-2484","authenticated-orcid":false,"given":"Avik","family":"Shome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odunayo O.","family":"Mugisho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael L.","family":"Niederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5997-5994","authenticated-orcid":false,"given":"Ilva D.","family":"Rupenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178442_bib1","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.2147\/JIR.S288294","article-title":"Topical anti-inflammatory agents for non-infectious uveitis: current treatment and perspectives","volume":"15","author":"Balasubramaniam","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/0301-4738.156914","article-title":"Experimental autoimmune uveitis and other animal models of uveitis: an update","volume":"63","author":"Bansal","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178442_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear Factor-\u03baB \u2014 a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178442_bib4","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.2174\/1381612821666150909094907","article-title":"Controversies in the pharmacological treatment of uveitis","volume":"21","author":"Barry","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2025.178442_bib5","first-page":"1891","article-title":"Pharmacotherapy for uveitis: current management and emerging therapy","volume":"8","author":"Barry","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178442_bib6","article-title":"Evaluation of ocular tolerability and bioavailability of tonabersat transfersomes ex vivo","author":"Bhujbal","year":"2025","journal-title":"Drug. Deliv. Transl. Technol."},{"key":"10.1016\/j.ejphar.2025.178442_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2008.09.005","article-title":"Progress report on new antiepileptic drugs: a summary of the ninth Eilat conference (EILAT IX)","volume":"83","author":"Bialer","year":"2009","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib8","article-title":"Corticosteroid implants for chronic non\u2010infectious uveitis","volume":"12","author":"Brady","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2025.178442_bib9","doi-asserted-by":"crossref","first-page":"38703","DOI":"10.1074\/jbc.M111.275370","article-title":"Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome","volume":"286","author":"Busillo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178442_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000119871","article-title":"Mouse models of experimental autoimmune Uveitis","volume":"40","author":"Caspi","year":"2008","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejphar.2025.178442_bib12","series-title":"Immunopharmacology and Inflammation","first-page":"249","article-title":"Glucocorticoids: molecular mechanisms of action","author":"Cruz-Topete","year":"2018"},{"key":"10.1016\/j.ejphar.2025.178442_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.preteyeres.2015.09.004","article-title":"Connexin43 in retinal injury and disease","volume":"51","author":"Danesh-Meyer","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib14","doi-asserted-by":"crossref","first-page":"15958","DOI":"10.1074\/jbc.270.27.15958","article-title":"Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake (\u2217)","volume":"270","author":"De Vos","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178442_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1189\/jlb.1102535","article-title":"Control of myeloid activity during retinal inflammation","volume":"74","author":"Dick","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2025.178442_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2016.00078","article-title":"The pro-inflammatory effects of glucocorticoids in the brain","volume":"7","author":"Duque","year":"2016","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2025.178442_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2025.178442_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2019.00210","article-title":"Glucocorticoid-driven NLRP3 inflammasome activation in hippocampal microglia mediates chronic stress-induced depressive-like behaviors","volume":"12","author":"Feng","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178442_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12165288","article-title":"Long-term outcomes of birdshot chorioretinopathy treated with corticosteroids: a case reports","volume":"12","author":"Ferracci","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejphar.2025.178442_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/antiox11010004","article-title":"Dexamethasone administration in mice leads to less body weight gain over time, lower serum glucose, and higher insulin levels independently of nrf2","volume":"11","author":"Filippopoulou","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2025.178442_bib21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000510212","article-title":"The role of gut microbiome in autoimmune uveitis","volume":"64","author":"Fu","year":"2020","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124223","article-title":"Focus on the role of NLRP3 inflammasome in diseases","volume":"21","author":"Fusco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178442_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/1744666X.2020.1798230","article-title":"The current status of biological treatment for uveitis","volume":"16","author":"Gaggiano","year":"2020","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.ejphar.2025.178442_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","article-title":"Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism","volume":"43","author":"Geer","year":"2014","journal-title":"Endocrinol Metab. Clin. N. Am."},{"key":"10.1016\/j.ejphar.2025.178442_bib25","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/bjophthalmol-2013-304421","article-title":"Evaluation of mouse experimental autoimmune uveoretinitis by spectral domain optical coherence tomography","volume":"98","author":"Harimoto","year":"2014","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178442_bib26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/ceo.13511","article-title":"New therapies in development for the management of non-infectious uveitis: a review","volume":"47","author":"Hassan","year":"2019","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178442_bib27","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00417-010-1485-8","article-title":"Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease","volume":"248","author":"Heiligenhaus","year":"2010","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178442_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5065703","article-title":"The microbiota determines susceptibility to experimental autoimmune uveoretinitis","volume":"2016","author":"Heissigerova","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/icb.2014.125","article-title":"Non-transcriptional regulation of NLRP3 inflammasome signaling by IL-4","volume":"93","author":"Hwang","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.178442_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/hum.2014.089","article-title":"Gene delivery of a viral anti-inflammatory protein to combat ocular inflammation","volume":"26","author":"Ildefonso","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ejphar.2025.178442_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115861","article-title":"Intranasal curcumin and dexamethasone combination ameliorates inflammasome (NLRP3) activation in lipopolysachharide exposed asthma exacerbations","volume":"436","author":"Jaiswal","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178442_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1167\/iovs.07-0371","article-title":"Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice","volume":"49","author":"Jiang","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2025.178442_bib33","doi-asserted-by":"crossref","first-page":"36617","DOI":"10.1074\/jbc.M112.407130","article-title":"Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation","volume":"287","author":"Juliana","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178442_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40135-023-00312-z","article-title":"Update on immune checkpoint inhibitor-associated uveitis","volume":"11","author":"Kim","year":"2023","journal-title":"Curr. Ophthalmol. Rep."},{"key":"10.1016\/j.ejphar.2025.178442_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12950-015-0086-z","article-title":"Increased expression of the NLRP3 inflammasome components in patients with Beh\u00e7et\u2019s disease","volume":"12","author":"Kim","year":"2015","journal-title":"J. Inflamm."},{"key":"10.1016\/j.ejphar.2025.178442_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5115\/acb.21.227","article-title":"Blood-retina barrier dysfunction in experimental autoimmune uveitis: the pathogenesis and therapeutic targets","volume":"55","author":"Kim","year":"2022","journal-title":"Anatomy Cell Biol."},{"key":"10.1016\/j.ejphar.2025.178442_bib37","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.ymthe.2018.03.012","article-title":"Complement-mediated activation of the NLRP3 inflammasome and its inhibition by AAV-mediated delivery of CD59 in a model of uveitis","volume":"26","author":"Kumar","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2025.178442_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.yexcr.2014.08.040","article-title":"IL-1\u03b2 induces IL-6 production in retinal M\u00fcller cells predominantly through the activation of P38 MAPK\/NF-\u03baB signaling pathway","volume":"331","author":"Liu","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/ijms22010298","article-title":"Tonabersat inhibits connexin43 hemichannel opening and inflammasome activation in an in vitro retinal epithelial cell model of diabetic retinopathy","volume":"22","author":"Lyon","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178442_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.steroids.2015.12.016","article-title":"Time-course changes of catabolic proteins following muscle atrophy induced by dexamethasone","volume":"107","author":"Macedo","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.ejphar.2025.178442_bib41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.survophthal.2022.06.003","article-title":"The inflammasome pathway: a key player in ocular surface and anterior segment diseases","volume":"68","author":"Mandell","year":"2023","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178442_bib42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jtos.2019.01.008","article-title":"Autophagy in corneal health and disease: a concise review","volume":"17","author":"Martin","year":"2019","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejphar.2025.178442_bib43","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/JLB.3MR0720-513R","article-title":"NLRP3 inflammasome priming: a riddle wrapped in a mystery inside an enigma","volume":"108","author":"McKee","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2025.178442_bib44","article-title":"Outcomes important to patients with non-infectious posterior segment-involving uveitis: a qualitative study","volume":"5","author":"Mohammad","year":"2020","journal-title":"BMJ Open Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178442_bib45","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.3390\/ijms24043876","article-title":"Orally delivered Connexin43 hemichannel blocker, tonabersat, inhibits vascular breakdown and inflammasome activation in a mouse model of diabetic retinopathy","volume":"24","author":"Mugisho","year":"2023","journal-title":"Int. J. Mol."},{"key":"10.1016\/j.ejphar.2025.178442_bib46","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/14728222.2019.1673368","article-title":"Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease","volume":"23","author":"Mugisho","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejphar.2025.178442_bib47","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/09273948.2020.1849735","article-title":"Melanocortin 5 receptor expression and recovery of ocular immune privilege after uveitis","volume":"30","author":"Ng","year":"2022","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.ejphar.2025.178442_bib48","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s13311-019-00786-5","article-title":"Connexin hemichannel block using orally delivered tonabersat improves outcomes in animal models of retinal disease","volume":"17","author":"Nor","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejphar.2025.178442_bib49","first-page":"9989","volume":"vol.116","author":"Okunuki","year":"2019"},{"key":"10.1016\/j.ejphar.2025.178442_bib50","first-page":"15","article-title":"Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives","volume":"8","author":"Ozaki","year":"2015","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib51","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2025.178442_bib52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00011-011-0404-8","article-title":"The NLRP3 inflammasome is active but not essential in endotoxin-induced uveitis","volume":"61","author":"Rosenzweig","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib53","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.imbio.2012.07.020","article-title":"Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction","volume":"217","author":"Schroder","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejphar.2025.178442_bib54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.exer.2005.07.008","article-title":"Severe chronic experimental autoimmune uveitis (EAU) of the C57BL\/6 mouse induced by adoptive transfer of IRBP1\u201320-specific T cells","volume":"82","author":"Shao","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib55","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1016\/j.drudis.2021.06.017","article-title":"Blocking the inflammasome: a novel approach to treat uveitis","volume":"26","author":"Shome","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2025.178442_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11072022","article-title":"Comprehensive grading system for experimental autoimmune Uveitis in mice","volume":"11","author":"Shome","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2025.178442_bib57","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/ame2.70011","article-title":"The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitis","volume":"8","author":"Shome","year":"2025","journal-title":"Animal Models Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178442_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-2982.2009.01974.x","article-title":"Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraineceph","volume":"29","author":"Silberstein","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.ejphar.2025.178442_bib59","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0021-5155(01)00369-0","article-title":"Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis","volume":"45","author":"Takeuchi","year":"2001","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178442_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.ejphar.2025.178442_bib61","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/15384047.2017.1394549","article-title":"Dexamethasone exacerbates cytotoxic chemotherapy induced lethargy and weight loss in female tumor free mice","volume":"19","author":"Wong","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejphar.2025.178442_bib62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.exer.2008.06.012","article-title":"A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images","volume":"87","author":"Xu","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108618","article-title":"The role of the inflammasomes in the pathogenesis of uveitis","volume":"208","author":"Xu","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib64","doi-asserted-by":"crossref","first-page":"12716","DOI":"10.1111\/jcmm.15849","article-title":"Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation","volume":"24","author":"Yang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2025.178442_bib65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12031-016-0874-9","article-title":"NLRP3 is required for complement-mediated Caspase-1 and IL-1beta activation in ICH","volume":"61","author":"Yao","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178442_bib66","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.23954","article-title":"Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2025.178442_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1109938","article-title":"The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors","volume":"13","author":"Zhan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178442_bib68","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.intimp.2017.05.039","article-title":"Chronic dexamethasone treatment results in hippocampal neurons injury due to activate NLRP1 inflammasome in vitro","volume":"49","author":"Zhang","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2025.178442_bib69","article-title":"NLRP3 inflammasome: checkpoint connecting innate and adaptive immunity in autoimmune diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178442_bib70","article-title":"Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis","author":"Zhong","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejphar.2025.178442_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124294","article-title":"Cellular models and assays to study NLRP3 inflammasome biology","volume":"21","author":"Zito","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:09:22Z","timestamp":1773918562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925011963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":71,"alternative-id":["S0014299925011963"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178442","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiting the NLRP3 inflammasome pathway: An effective way to treat chronic inflammation in experimental autoimmune uveitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178442"}}